All-time M&A record for life sciences in 2019 as companies increased therapy area focus and closed growth gaps

SAN FRANCISCO, Jan. 13, 2020 /PRNewswire/ — Life sciences mergers and acquisitions (M&A) activity, driven by pharmaceutical buyers, totaled an unprecedented US$357b in 2019 (as of 30 November), breaking the 2014 record. Medical technology and biotechnology companies remained on the…

About the Author

has written 21810 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com